DR. REDDYS LABORATORIES, INC — Valsartan Importer Profile
Pharmaceutical Importer · #11 buyer for Valsartan · $2.8M import value · 75 shipments · UNITED STATES · DGFT Verified
DR. REDDYS LABORATORIES, INC is the #11 importer of Valsartan from India with $2.8M in import value and 75 verified shipments. DR. REDDYS LABORATORIES, INC holds a 1.9% market share in Valsartan imports based in UNITED STATES. The company sources from 1 verified supplier across 37 formulations shipped to 1 country. Overall, DR. REDDYS LABORATORIES, INC imports 6 pharmaceutical products worth $9.1M across 5 therapeutic categories.
DR. REDDYS LABORATORIES, INC — Valsartan Import Profile: Suppliers, Formulations & Sources
Who Actually Supplies Valsartan to DR. REDDYS LABORATORIES, INC?
Verified from 75 customs shipment records
| Supplier | Value | Shipments | % Share |
|---|---|---|---|
| DR.REDDY'S LABORATORIES LIMITED | $2.8M | 75 | 100.0% |
DR. REDDYS LABORATORIES, INC sources Valsartan from 1 verified Indian supplier based on 75 customs records. The primary supplier is DR.REDDY'S LABORATORIES LIMITED accounting for 100.0% of imports.
How Does DR. REDDYS LABORATORIES, INC Compare to Nearest Valsartan Importers?
Buyers ranked immediately above and below #11 by import value
| # | Buyer | Country | Import Value | Shipments | Avg/Shipment |
|---|---|---|---|---|---|
| 5 | MYLAN PHARMACEUTICALS INC | UNITED STATES | $3.5M | 69 | $50.0K |
| 6 | LEK D.D | SLOVENIA | $3.4M | 67 | $50.0K |
| 11 | DR. REDDYS LABORATORIES, INC ★ | UNITED STATES | $3.0M | 60 | $50.0K |
| 3 | MACLEODS PHARMA USA,INC | UNITED STATES | $3.0M | 59 | $50.0K |
| 14 | KAWKAB SCIENTIFIC BUREAU* | IRAQ | $2.4M | 78 | $30.9K |
DR. REDDYS LABORATORIES, INC ranks #11 among 663 Valsartan importers from India. Average shipment value of $50.0K compared to the market average of $71.0K. The closest competitors by value are MYLAN PHARMACEUTICALS INC and LEK D.D.
Where Does DR. REDDYS LABORATORIES, INC Import Valsartan To?
Destination countries from 75 verified shipments
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $2.8M | 75 | 100.0% |
DR. REDDYS LABORATORIES, INC imports Valsartan to 1 country. The primary destination is UNITED STATES receiving 100.0% of shipments worth $2.8M.
What Valsartan Formulations Does DR. REDDYS LABORATORIES, INC Import?
| Formulation | Value | Shipments |
|---|---|---|
| VALSARTAN TABLETS USP 320MG 90S (TOTAL | $750.0K | 15 |
| VALSARTAN TABLETS USP 80MG 90S (TOTAL Q | $385.1K | 11 |
| VALSARTAN TABLETS USP 160MG 90S (TOTAL | $300.0K | 6 |
| VALSARTAN TABLETS USP 160MG 90S (TOTALQTY PACKS 23678 X 90S=2131020 NOS)NOS | $101.0K | 3 |
| VALSARTAN TABLETS USP 160MG 90S (11826 | $100.0K | 2 |
| VALSARTAN TABLETS USP 40MG 30S (26460 P | $57.1K | 2 |
| VALSARTAN TABLETS USP 160MG 90S (11640 | $50.0K | 1 |
| VALSARTAN TABLETS USP 160MG 90S (23544 | $50.0K | 1 |
| VALSARTAN TABLETS USP 320MG 90S (11456 | $50.0K | 1 |
| VALSARTAN TABLETS USP 160MG 90S (23561 | $50.0K | 1 |
DR. REDDYS LABORATORIES, INC imports 37 distinct Valsartan formulations from India. The top formulation is VALSARTAN TABLETS USP 320MG 90S (TOTAL with 15 shipments worth $750.0K.
Regulatory Requirements: Importing Valsartan into United States
What DR. REDDYS LABORATORIES, INC and other importers must comply with to import Valsartan from India
Regulatory Authority
U.S. Food and Drug Administration (FDA)
Approval Process for Generic Valsartan
Abbreviated New Drug Application (ANDA) for generic drugs, requiring bioequivalence studies and compliance with 21 CFR. Indian manufacturing sites must pass FDA pre-approval inspection.
Typical timeline: 10–18 months for ANDA approval
GMP Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA prior to approval
Import Licence & Documentation
Drug Listing with FDA; Import Alert screening; Customs entry via FDA PREDICT system
Labeling & Packaging
US-specific labeling per 21 CFR 201 including NDC number, lot, expiry, dosage in English
Note: Subject to FDA Import Alerts and Automatic Detention if facility has open Form 483 observations.
Regulatory information is provided for general reference based on publicly available FDA guidelines for pharmaceutical imports. Requirements may vary by specific drug formulation, dosage form, and therapeutic classification. Importers should consult directly with FDA or qualified regulatory affairs professionals for case-specific guidance.
Who Are the Top Buyers of Valsartan from India and How Much Does DR. REDDYS LABORATORIES, INC Import?
India exported $47.1M worth of Valsartan through 6,098 shipments from 259 suppliers to 119 countries, serving 663 buyers globally. DR. REDDYS LABORATORIES, INC imports $2.8M of this total, accounting for 1.9% of India's Valsartan exports with 75 shipments from UNITED STATES. This is verified from 75 customs shipment records covering 37 distinct formulations.
What Is the Average Order Value for DR. REDDYS LABORATORIES, INC's Valsartan Imports?
DR. REDDYS LABORATORIES, INC's average Valsartan order value is $37.8K per consignment, based on 75 shipments totaling $2.8M. DR. REDDYS LABORATORIES, INC is based in UNITED STATES and ranks #11 among all Valsartan importers from India by value. The company sources from 1 verified supplier in India.
Who Supplies Valsartan to DR. REDDYS LABORATORIES, INC?
DR. REDDYS LABORATORIES, INC sources Valsartan from 1 verified Indian supplier: DR.REDDY'S LABORATORIES LIMITED ($2.8M, 100.0%). This is based on 75 customs records.
How Does DR. REDDYS LABORATORIES, INC Compare to Other Valsartan Importers?
DR. REDDYS LABORATORIES, INC ranks #11 among 663 Valsartan importers from India with a 1.9% market share. The top 3 importers are MYLAN PHARMACEUTICALS INC, ($4.7M), YUSEN LOGISTICS BENELUX BELGIUM ($4.5M), MYLAN HUNGARY KFT, ($4.5M). DR. REDDYS LABORATORIES, INC processed 75 shipments from UNITED STATES.
About DR. REDDYS LABORATORIES, INC
DR. REDDYS LABORATORIES, INC imports 6 products worth $9.1M. Beyond Valsartan, top products include Metoprolol, Clopidogrel, Doxorubicin, Ciprofloxacin, Dexamethasone. View the complete DR. REDDYS LABORATORIES, INC profile for full portfolio analysis.
Market Intelligence
Latest developments and market context
Detailed market intelligence for Valsartan — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Official References & Regulatory Resources
- European Medicines Agency
- WHO Essential Medicines
- Invest India — Pharma Sector
- India Trade Statistics (DGFT)
Verify import regulations and drug registration requirements with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Product Matching: Valsartan shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature and HS code classification.
- 2.Buyer Identification: DR. REDDYS LABORATORIES, INC matched across shipments using first-3-word normalization of the consignee field, accounting for company name formatting variations.
- 3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort buyer rankings.
- 4.Market Share: Calculated as DR. REDDYS LABORATORIES, INC's capped import value divided by total capped export value for Valsartan across all Indian exporters.
- 5.Verified Records: This page is backed by 75 individual customs records matching DR. REDDYS LABORATORIES, INC importing Valsartan, covering 37 formulations from 1 verified supplier.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 119+ countries, 663+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Get Valsartan Import Data for DR. REDDYS LABORATORIES, INC
Access order-level details, pricing data, supplier connections, and competitive analysis for DR. REDDYS LABORATORIES, INC's Valsartan imports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
DR. REDDYS LABORATORIES, INC
Full Company Profile →
6 products · $9.1M total trade · 5 categories
DR. REDDYS LABORATORIES, INC × Valsartan
Verified from customs records
Company Overview
Top Products by DR. REDDYS LABORATORIES, INC
Related Analysis
Need Detailed Import Data?
Access shipment-level records, supplier contacts, and formulation details for DR. REDDYS LABORATORIES, INC.
Request DemoView Pricing →Data Source
Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Valsartan. For current order-level data, contact TransData Nexus.